From July 1, 2023 to August 3, 2023, the company has repurchased 0 shares, representing 0% for KRW 0 million. With this, the company has completed the repurchase of 324,118 shares, representing 0.97% for KRW 2,997.54 million under the buyback announced on December 2, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
6,520 KRW | -0.31% | -5.78% | -25.74% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-25.74% | 16Cr | |
+7.39% | 11TCr | |
+11.38% | 11TCr | |
-12.64% | 2.22TCr | |
+0.44% | 2.13TCr | |
-4.18% | 1.9TCr | |
-37.85% | 1.85TCr | |
-8.57% | 1.68TCr | |
+37.41% | 1.25TCr | |
-24.07% | 808.97Cr |
- Stock Market
- Equities
- A048530 Stock
- News iNtRON Biotechnology, Inc.
- Tranche Update on iNtRON Biotechnology, Inc.'s Equity Buyback Plan announced on December 2, 2022.